CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Cognitive Behavioral Therapy, Obsessive-Compulsive Disorder, Obsessive-Compulsive Disorder in Children, Obsessive-Compulsive Disorder in Adolescence

In brief

The purpose of this study is to examine whether youth with OCD who benefit from CBT augmentation to SRI can discontinue their medication without relapse over 24 weeks.

Key facts

Study ID
NCT05609916
Run by
Baylor College of Medicine
People needed
200
Starts
2022-11-30
Expected to finish
2027-08-30
Last updated by the study team
2026-08-04

Who can join

Age: 7 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.